Left panel. CEM.SS T cells were infected with a normalized mixture, at 1:1 ratio, of HIV-1.mRFP.vpr.wt and HIV-1.RFP.vpr.Δ at a low moi. The cell-associated HIV-1 DNA in the infected cultures was quantified at 3, 5 and 7 days post infection (dpi), by real time PCR and using vpr.wt and vpr.Δ amplicons. The relative percentage of cell-associated HIV-1 DNA from each of the competing viruses over time is shown in panel 1. The data are representative of three biological replicate experiments. Right panel. The relative percentage of each competing virus in the inocula (INPUT) and of cell-associated DNA at 7dpi, determined for three biological replicate experiments, is shown in panel 2. Statistical significance of differences between competing viruses was determined using T-test. *** -p<0.001. CEM.SS T cells were infected with a normalized mixture, at 1:1 ratio, of HIV-1.vpr.wt and HIV-1.RFP.vpr.Δ at three different low mois, in triplicate for each moi. The viruses did not contain the RFP/mRFP-IRES cassettes or any other exogenous sequences, and their env-nef sequences were as in the HIV-1 NL4-3 molecular clone. A. Concentrated viral particles were normalized following CA quantification by immunoblotting. B. Cell-associated HIV-1 DNA in the infected cultures was quantified at 7dpi by real time PCR with vpr.wt and vpr.Δ amplicons. C. Foldchange in cell-associated HIV-1 DNA, normalized to that seen for HIV-1 with the inactivated vpr.Δ allele. D. Relative percentage of each competing virus in the inocula (INPUT) and of cellassociated DNA at 7dpi. Statistical significance of differences between competing viruses was determined using T-test. *** -p<0.001, **** -p<0.0001. PRCA was performed with four pairs of viruses carrying vpr.wt or vpr.Q8* alleles and BFP or RFP genes, in different combinations, as indicated by blue and red fonts. All viruses were normalized by single cycle infection assays with CEM.SS T cells, mixed at approximately 1:1 ratio, and the mixtures were used to infect CEM.SS T cells at three different mois. The infected cultures were characterized at days 3, 5 and 7 dpi by flow cytometry. The datasets were gated minimally on side and forward scatter to eliminate cell debris but not cells with abnormal scatter profiles or cell aggregates. This was done to avoid possible analysis bias, as HIV-1 infected cells may have an appearance of dying cells that would otherwise be gated out, and because the survival of the infected cells could be influenced by vpr expression. It is evident that (i) the competing vpr.wt viruses expressing RFP or BFP replicated similarly (panel A), (ii) vpr.Q8* viruses expressing RFP or BFP also replicated similarly (panel B), and (iii) the fraction of cells expressing the reporter proteins was several-fold higher in cultures infected with vpr.wt viruses, compared to those with the defective vpr.Q8* alleles (compare panel A with panel B). The positive effect of vpr on HIV-1 replication was also clearly seen when the vpr.wt and vpr.Q8* viruses competed directly (panels C, D). Lysates of U2OS_iH1vpr (iH1vpr) and control U2OS cells (mock), cultured in the absence or presence of doxycycline (100ng/ml) for 48 hours, were immunoblotted for the indicated HUSH complex subunits. 
